Compound Detail
CHEMBL611024
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
C[C@H]1[C@@H](Oc2cccc(N[C@@H]3[C@H](C)O[C@@H]4O[C@@]5(C)CC[C@H]6[C@H](C)CC[C@@H]3[C@@]46OO5)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3
Basic Information
| ChEMBL ID | CHEMBL611024 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FBJOCQUDHHHWSE-WOKIIMGKSA-N |
4
Targets
5
Activities
1
Assay Types
0
PK Parameters
18
Publications
0
Known Names
Molecular Properties
641.8
MW (Da)
6.69
ALogP
10
HBA
1
HBD
95.1
PSA (Ų)
0.36
QED
2
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 5 meas. best 8.24
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Plasmodium falciparum CHEMBL364 | IC50 | 8.24 | 8.235 | 5.8 | 2 |
| Cryptococcus neoformans CHEMBL365 | IC50 | 6.8 | 6.8 | 160.0 | 1 |
| Escherichia coli CHEMBL354 | IC50 | 5.07 | 5.07 | 8570.0 | 1 |
| Leishmania donovani CHEMBL367 | IC50 | 4.6 | 4.6 | 24900.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Plasmodium falciparum | IC50 | = | 5.8 | nM | 8.24 | Antiplasmodial activity against Plasmodium falciparum D6 infected in RBCs by par... | 19879765 |
| Plasmodium falciparum | IC50 | = | 5.9 | nM | 8.23 | Antiplasmodial activity against Plasmodium falciparum W2 infected in RBCs by par... | 19879765 |
| Cryptococcus neoformans | IC50 | = | 160.0 | nM | 6.8 | Antifungal activity against Cryptococcus neoformans ATCC 90113 by modified CLSI/... | 19879765 |
| Escherichia coli | IC50 | = | 8570.0 | nM | 5.07 | Antibacterial activity against Escherichia coli ATCC 35218 by modified CLSI/NCCL... | 19879765 |
| Leishmania donovani | IC50 | = | 24900.0 | nM | 4.6 | Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs ... | 19879765 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 19879765 | 10.1016/j.bmc.2009.10.019 | Leishmania donovani | 2 |
| 19879765 | 10.1016/j.bmc.2009.10.019 | Vero | 2 |
| 19879765 | 10.1016/j.bmc.2009.10.019 | Staphylococcus aureus | 2 |
| 19879765 | 10.1016/j.bmc.2009.10.019 | Plasmodium falciparum | 2 |
| 19879765 | 10.1016/j.bmc.2009.10.019 | Unchecked | 2 |
| 19879765 | 10.1016/j.bmc.2009.10.019 | Cryptococcus neoformans | 1 |
| 19879765 | 10.1016/j.bmc.2009.10.019 | Escherichia coli | 1 |
| 19879765 | 10.1016/j.bmc.2009.10.019 | Pichia kudriavzevii | 1 |
| 19879765 | 10.1016/j.bmc.2009.10.019 | Nakaseomyces glabratus | 1 |
| 19879765 | 10.1016/j.bmc.2009.10.019 | ADMET | 1 |
| 19879765 | 10.1016/j.bmc.2009.10.019 | Mycobacterium intracellulare | 1 |
| 19879765 | 10.1016/j.bmc.2009.10.019 | Pseudomonas aeruginosa | 1 |
| 19879765 | 10.1016/j.bmc.2009.10.019 | Aspergillus fumigatus | 1 |
| 19879765 | 10.1016/j.bmc.2009.10.019 | Candida albicans | 1 |
| 19879765 | 10.1016/j.bmc.2009.10.019 | SK-OV-3 | 1 |
| 19879765 | 10.1016/j.bmc.2009.10.019 | BT-549 | 1 |
| 19879765 | 10.1016/j.bmc.2009.10.019 | KB | 1 |
| 19879765 | 10.1016/j.bmc.2009.10.019 | SK-MEL | 1 |
Data from ChEMBL 36 via Core Engine